Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ureteral Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 18 Prostatic Neoplasms 8 Liver Neoplasms 6 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Neoplasms 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Melanoma 1 Liver, Cancer of, Non-Resectable 1 Liver Metastasis Colon Cancer 1 Laryngeal Neoplasms 1 Gynecological Cancers 1

Interventions

Gemcitabine 6 pembrolizumab 4 Cisplatin 4 enfortumab vedotin 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Carboplatin 3 vinflunine 2 avelumab 2 Radiotherapy 2 Nephroureterectomy 2 Immunoglobulin G 2 Disulfides 2 vandetanib 1 tremelimumab 1 tocilizumab 1 tamibarotene 1 genexol-PM 1 enzalutamide 1 durvalumab 1 dehydroftorafur 1 abexinostat 1 Vitamin D 1 Vitamin B 12 1 Standard of Care 1 Sorafenib 1 Radiation 1 Practice Guidelines as Topic 1 Platinum 1 Plasmapheresis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430779 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡